Patent details

Basic Information

Publication number:

EP2125698

PCT Application Number:

PCT/US/2008/056780

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087320842

PCT Publication Number:

WO/2008/140859

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEUTERATED d9-VENLAFAXINE

French Title of Invention:

d9-VENLAFAXINE DEUTERE

German Title of Invention:

DEUTERIERTES d9-VENLAFAXINE

SPC Number:

Dates

Filing date:

13/03/2008

Grant date:

31/08/2016

EP Publication Date:

31/08/2016

PCT Publication Date:

20/11/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/12/2009

EP B1 Publication Date:

31/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/03/2019

Expiration date:

13/03/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/10/2016

 

 

Name:

Auspex Pharmaceuticals Inc.

Address:

3333 North Torrey Pine Court, Suite 400, La Jolla, CA 92037, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

19/10/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

GANT Thomas, G.

Address:

United States (US)

2

Name:

WOO Soon, Hyung

Address:

United States (US)

3

Name:

SEPEHR Sarshar

Address:

United States (US)

Priority

1

Priority Number:

895049 P

Priority Date:

15/03/2007

Priority Country:

United States (US)

2

Priority Number:

944399 P

Priority Date:

15/06/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07C 217/74;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

21/03/2018

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

148 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages